The Chembio program at UC Berkeley is hosting a career day on June 15 in 106 Stanley Hall from 1-4 pm. A panel will speak on the different options available to those starting with a scientific background. The event will be a relaxed networking event with plenty of time for question-answering on the job hunt, postdoc search, tricks to get noticed, and what to avoid in getting to the next stage of your career. Registration is requested.
The moderator for the event is Professor Carolyn Bertozzi, the T.Z. and Irmgard Chu Distinguished Professor of Chemistry and Professor of Molecular and Cell Biology at UC Berkeley, Investigator of the Howard Hughes Medical Institute, and Senior Faculty Scientist at the Lawrence Berkeley National Laboratory.
Thomas Baker is a consultant at the San Francisco office of the Boston Consulting Group (BCG). At BCG, his expertise is energy (clean-tech, utilities, and oil & gas) and social impact (corporate social responsibility and the environment). Prior to joining BCG, Thomas worked in the strategic marketing department of First Solar and prior to that as a post-doctoral researcher in the Martin Head-Gordon group in the chemistry department at Berkeley. Thomas holds a Ph.D. in chemical physics from Harvard University and a B.S. in chemistry from Indiana University of Pennsylvania.
William Belknap, Research Leader, The Crop Improvement and Utilization Research Unit, USDA
Dr. William Belknap is Research Leader of the Crop Improvement and Utilization Research Unit, Western Regional Research Center. His childhood was spent on a family farm in Oldham County, Kentucky. He completed his undergraduate work (BA) at Macalester College (St. Paul, MN) with chemistry and biology majors, and a minor in mathematics. He did his graduate work (PhD) at Indiana University (Bloomington, IN) in plant physiology/biochemistry (enzymology/intermediary metabolism) studying photosynthetic carbon metabolism. This was followed by post-docs in biochemistry at the University of Illinois (Urbana,IL) and in molecular genetics at the University of Chicago. He has been been at the USDA in Albany, CA for the past 25 years applying molecular genetics to crop improvement (currently potatoes and citrus).
Kyle Broaders is a postdoctoral scholar in the laboratories of Professor Zev Gartner at UCSF. He is currently investigating the role of microarchitecture on cellular behavior by interfacing the tools of materials chemistry with tissue biology. He received his PhD in 2011 in the Chemistry Department at UC Berkeley under Professor Jean M.J. Fréchet, researching degradable polymers for drug and protein delivery applications. Kyle graduated with high honors from Swarthmore College where he researched the synthesis of non-biaryl atropisomeric phosphines under Professor Robert S. Paley.
Rachel earned her BA in Biochemistry at the University of Pennsylvania in 2005. She earned her Ph.D. in 2011 for her work studying protein folding in Susan Marqusee’s lab. While at Berkeley, she was also very involved with the Berkeley Science Review as author, Editor, Managing Editor, and Editor in Chief over four years. She is now an associate editor at the multidisciplinary open access journal PLoS ONE, where she works with academic editors, authors, and reviewers to ensure best practices in editing and publishing and helps develop innovative academic publishing tools.
Kurt Deshayes is a senior scientist in Early Discovery Biochemistry Department at Genentech Inc. A native of Minnesota he received his bachelor degree in chemistry from Carleton College in Northfield. He obtained his Ph.D. with Jeffrey Winkler at the University of Chicago. After postdoctoral studies with D.J. Cram at UCLA he set up a laboratory working in chemical recognition and chemical physics at Bowling Green. He moved to Genentech in 1997 to investigate problems in chemical biology. His group has been investigating how manipulating protein-protein interactions modulates cellular signaling. Recently, he has been involved in studies of proteins that inhibit programmed cell death (apoptosis) in cancer cells, and how these proteins help provide resistance to conventional treatments. His long term goal is the development of novel therapeutics that target the apoptosis pathway.
Adam de la Zerda, Damon Runyon Postdoctoral Fellow, UC Berkeley; Assistant Professor, Structural Biology Department, Stanford University School of Medicine
Dr. Adam de la Zerda is a Damon Runyon Postdoctoral Fellow at the Department of Chemistry at UC Berkeley under Prof. Carolyn Bertozzi. In September 2012, Dr. de la Zerda will assume an Assistant Professor position at the department of Structural Biology at the Stanford School of Medicine. He is an Entrepreneur in Residence (EIR) at the venture capitalist firm Artiman. He is interested in designing new molecular imaging technologies and exploring their application for ophthalmic and cancer imaging. Among his awards are: Era of Hope Distinguished Predoctoral Award, Young Investigator Award at the World Molecular Imaging Congress. He published over 13 papers, holds a number of patents and is the co-founder of a medical imaging device company, OcuBell Inc. Dr. de la Zerda completed his Ph.D. studies in 2011 at the department of Electrical Engineering at Stanford University under the mentorship of Prof. Sam Gambhir. Previously, he studied Computer Engineering at the Technion – Israel Institute of Technology where he graduated with a B.Sc. Summa Cum Laude.